Tutaj ważniejsze jest co innego ale nikt tego nie zauważył. It's a very important day for Cannprisma-Pharma and Cosma Cannabis as we signed an exclusivity agreement for the distribution of premium quality medical-grade cannabis in Poland.   We are thrilled with this landmark as it represents the opportunity to provide Polish Patients access to high-quality cannabis-based medicines, and to fulfil our most important mission, to improve the health and welfare of patients worldwide.    This partnership is the fruit of effort, transparency, and social responsibility among the two companies that combine synergies following a thorough ethical code with the mutual goal of attending to the patient's needs with safe cannabis-based solutions and to keep pushing the industry forward!   Cosma Cannabis will register several strains of CannPrisma premium cannabis flowers in Poland and expects to add premium quality cannabis extracts/tinctures to its portfolio in near future. Companies are looking for fruitful cooperation not only in the field of medicines distribution but also in R&D projects. Poland is a country of 38 million people where only 11 medical cannabis products are registered. The potential for medical cannabis growth is big and the expected market value is 40-50% of the German market.